Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for TRML

Stock Name	Tourmaline Bio Inc.
Ticker	TRML(USD) NASDAQ
TYPE	Common Stock
Country	USA

Show aggregate TRML holdings

News associated with TRML

Truist Financial Downgrades Tourmaline Bio (NASDAQ:TRML) to Hold: Tourmaline Bio (NASDAQ:TRML – Get Free Report) was downgraded by equities research analysts at Truist Financial from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a $48.00 price target on the stock, down from their previous price target of […] - 2025-09-11 05:14:52
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 13:24:04
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 11:56:00
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 10:14:58
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 08:35:12
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 06:54:32
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 03:39:30
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $50.14 Average Target Price from Analysts: Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […] - 2025-09-10 02:32:51
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 00:27:19
Stocks Edge Higher on Expectations for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.07%, and September E-mini Nasdaq futures... - 2025-09-09 14:59:32
Stocks Turn Mixed as US Job Growth Less Than Previously Stated: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.08%. September E-mini S&P futures (ESU25 ) are down -0.08%, and September E-mini Nasdaq futures... - 2025-09-09 14:45:23
Stocks Edge Higher on Expectations for Fed Rate Cuts: The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.07%, and September E-mini Nasdaq futures... - 2025-09-09 12:48:35
Tourmaline Bio Agrees To Be Acquired By Novartis In $1.4 Bln Deal; Stock Up: (RTTNews) - Tourmaline Bio Inc. (TRML) announced Tuesday that it has agreed to be acquired by Novartis AG (NVS, NOVN.SW) for $48.00 per share in cash at closing, representing a total equity value of about $1.4 billion. The deal price represents a premium of 59% to Tourmalines clo - 2025-09-09 02:28:03
Federated Hermes Inc. Buys 120,322 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML): Federated Hermes Inc. increased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 13,036.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 121,245 shares of the company’s stock after acquiring an additional 120,322 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-06 05:13:00
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Consensus PT from Analysts: Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has received an average rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the last […] - 2025-06-27 02:37:04
GAMMA Investing LLC Grows Stake in Tourmaline Bio, Inc. (NASDAQ:TRML): GAMMA Investing LLC grew its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 4,481.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 7,514 shares of the company’s stock after acquiring an additional 7,350 shares during the quarter. GAMMA Investing LLC’s holdings in Tourmaline Bio were worth $114,000 at the […] - 2025-06-24 04:46:55
SG Americas Securities LLC Has $550,000 Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML): SG Americas Securities LLC lifted its position in Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 3.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,180 shares of the company’s stock after buying an additional 1,368 shares during the quarter. SG Americas […] - 2025-06-23 04:58:58
California State Teachers Retirement System Has $213,000 Stake in Tourmaline Bio, Inc. (NASDAQ:TRML): California State Teachers Retirement System increased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 527.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 10,505 shares of the company’s stock after buying an additional 8,832 shares during the quarter. California State Teachers Retirement System’s holdings in Tourmaline Bio were […] - 2025-06-13 05:02:51
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Consensus PT from Brokerages: Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the stock in the […] - 2025-06-02 03:09:00
Millennium Management LLC Has $7.40 Million Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML): Millennium Management LLC lowered its position in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 28.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 364,658 shares of the company’s stock after selling 144,757 shares during the quarter. Millennium […] - 2025-05-27 04:48:57
Head-To-Head Analysis: Tourmaline Bio (NASDAQ:TRML) vs. enGene (NASDAQ:ENGN): Tourmaline Bio (NASDAQ:TRML – Get Free Report) and enGene (NASDAQ:ENGN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Institutional & Insider Ownership 91.9% of Tourmaline Bio […] - 2025-05-14 02:20:48
Analysts Set Tourmaline Bio, Inc. (NASDAQ:TRML) Target Price at $49.33: Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been assigned a consensus rating of “Buy” from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have covered the stock in the last […] - 2025-05-08 02:04:55
Barclays PLC Acquires 26,733 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML): Barclays PLC grew its holdings in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 84.0% during the fourth quarter, Holdings Channel reports. The firm owned 58,566 shares of the company’s stock after purchasing an additional 26,733 shares during the period. Barclays PLC’s holdings in Tourmaline Bio were worth $1,187,000 as of its most […] - 2025-05-05 05:18:49
Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Chardan Capital: Stock analysts at Chardan Capital began coverage on shares of Tourmaline Bio (NASDAQ:TRML – Get Free Report) in a report issued on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $70.00 price target on the stock. Chardan Capital’s price objective would indicate a potential upside of 304.16% from the company’s current price. […] - 2025-04-25 04:24:47
Vanguard Group Inc. Acquires 43,652 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML): Vanguard Group Inc. boosted its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 4.1% in the 4th quarter, HoldingsChannel reports. The fund owned 1,106,125 shares of the company’s stock after buying an additional 43,652 shares during the quarter. Vanguard Group Inc.’s holdings in Tourmaline Bio were worth $22,432,000 at the end […] - 2025-04-16 04:28:51
Head to Head Survey: Tourmaline Bio (NASDAQ:TRML) vs. Vaxcyte (NASDAQ:PCVX): Vaxcyte (NASDAQ:PCVX – Get Free Report) and Tourmaline Bio (NASDAQ:TRML – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Profitability This table compares Vaxcyte and Tourmaline Bio’s net […] - 2025-02-21 04:34:51

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) TRML holdings

Date	Number of TRML Shares Held	Base Market Value of TRML Shares	Local Market Value of TRML Shares	Change in TRML Shares Held	Change in TRML Base Value	Current Price per TRML Share Held	Previous Price per TRML Share Held
2025-10-27 (Monday)	16,223	USD 778,380	USD 778,380	0	USD 0	USD 47.98	USD 47.98

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TRML by Blackrock for IE00BDZVHG35

Show aggregate share trades of TRML

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-20 BUY 84 47.930 47.945 47.943 USD 4,027 21.71
2025-10-17 BUY 210 47.900 47.920 47.918 USD 10,063 21.59
2025-10-15 BUY 336 47.890 47.920 47.917 USD 16,100 21.47
2025-10-09 BUY 480 47.850 47.920 47.913 USD 22,998 21.12
2025-10-06 BUY 126 47.870 47.900 47.897 USD 6,035 20.87
2025-10-03 BUY 294 47.900 47.900 47.900 USD 14,083 20.75
2025-10-02 BUY 42 47.870 47.940 47.933 USD 2,013 20.63
2025-09-30 BUY 84 47.830 47.900 47.893 USD 4,023 20.37
2025-09-26 BUY 84 47.740 47.765 47.762 USD 4,012 20.12
2025-09-25 BUY 84 47.720 47.770 47.765 USD 4,012 19.99
2025-09-24 SELL -708 47.750 47.760 47.759 USD -33,813 19.86 Loss of -19,755 on sale
2025-09-18 BUY 44 47.690 47.770 47.762 USD 2,102 19.72
2025-09-17 BUY 135 47.700 47.750 47.745 USD 6,446 19.59
2025-09-11 SELL -44 47.600 47.640 47.636 USD -2,096 19.05 Loss of -1,258 on sale
2025-09-10 BUY 88 47.600 47.640 47.636 USD 4,192 18.91
2025-09-05 SELL -45 26.740 28.455 28.283 USD -1,273 18.67 Loss of -433 on sale
2025-08-29 SELL -135 23.400 23.420 23.418 USD -3,161 18.57 Loss of -655 on sale
2025-08-27 BUY 90 23.515 24.560 24.455 USD 2,201 18.52
2025-08-26 SELL -45 23.505 23.580 23.572 USD -1,061 18.49 Loss of -229 on sale
2025-08-25 BUY 45 22.680 23.520 23.436 USD 1,055 18.47
2025-08-20 SELL -180 22.460 22.750 22.721 USD -4,090 18.43 Loss of -773 on sale
2025-08-18 BUY 90 22.170 22.845 22.777 USD 2,050 18.39
2025-08-08 SELL -90 20.720 21.670 21.575 USD -1,942 18.30 Loss of -295 on sale
2025-08-05 BUY 44 22.420 22.930 22.879 USD 1,007 18.24
2025-08-01 SELL -132 21.760 22.340 22.282 USD -2,941 18.20 Loss of -539 on sale
2025-07-30 BUY 176 23.340 23.810 23.763 USD 4,182 18.15
2025-07-17 SELL -90 18.600 18.930 18.897 USD -1,701 18.07 Loss of -74 on sale
2025-07-11 SELL -360 17.980 18.080 18.070 USD -6,505 18.06 Loss of -4 on sale
2025-07-07 BUY 135 15.960 16.380 16.338 USD 2,206 18.09
2025-07-02 BUY 2,475 16.190 16.500 16.469 USD 40,761 18.13
2025-06-25 BUY 90 16.990 17.230 17.206 USD 1,549 18.17
2025-06-11 BUY 90 19.095 19.900 19.819 USD 1,784 18.18
2025-06-10 BUY 90 19.000 19.120 19.108 USD 1,720 18.17
2025-06-04 SELL -46 18.730 19.350 19.288 USD -887 18.15 Loss of -52 on sale
2025-04-23 BUY 45 17.820 18.406 18.348 USD 826 18.69
2025-04-10 SELL -368 12.100 12.550 12.505 USD -4,602 19.02 Profit of 2,399 on sale
2025-04-08 SELL -45 12.220 13.400 13.282 USD -598 19.16 Profit of 264 on sale
2025-04-07 SELL -45 12.620 13.270 13.205 USD -594 19.23 Profit of 271 on sale
2025-04-04 SELL -230 12.830 13.120 13.091 USD -3,011 19.29 Profit of 1,427 on sale
2025-04-01 BUY 184 14.240 15.180 15.086 USD 2,776 19.41
2025-03-31 SELL -138 15.210 16.220 16.119 USD -2,224 19.45 Profit of 460 on sale
2025-03-21 BUY 1,284 17.150 17.460 17.429 USD 22,379 19.62
2025-03-14 SELL -672 18.800 18.820 18.818 USD -12,646 19.75 Profit of 626 on sale
2025-03-07 SELL -84 14.380 15.660 15.532 USD -1,305 20.01 Profit of 377 on sale
2025-03-04 SELL -42 12.420 12.760 12.726 USD -534 20.29 Profit of 318 on sale
2025-02-25 BUY 84 12.550 12.720 12.703 USD 1,067 20.84
2025-02-19 SELL -42 12.600 13.090 13.041 USD -548 21.36 Profit of 349 on sale
2025-02-13 BUY 126 13.090 13.745 13.679 USD 1,724 21.88
2025-02-12 BUY 42 13.230 13.250 13.248 USD 556 22.02
2025-02-11 BUY 168 12.880 13.760 13.672 USD 2,297 22.17
2025-01-17 BUY 164 18.000 18.195 18.175 USD 2,981 24.48
2025-01-16 BUY 164 17.330 18.540 18.419 USD 3,021 24.66
2025-01-10 SELL -82 19.700 20.210 20.159 USD -1,653 25.27 Profit of 419 on sale
2025-01-08 SELL -164 20.000 20.350 20.315 USD -3,332 25.57 Profit of 861 on sale
2024-12-30 SELL -2,182 20.080 20.460 20.422 USD -44,561 25.88 Profit of 11,917 on sale
2024-11-18 SELL -705 24.520 25.730 25.609 USD -18,054 27.22 Profit of 1,133 on sale
2024-11-08 SELL -47 28.760 29.545 29.467 USD -1,385 27.18 Loss of -107 on sale
2024-10-21 SELL -47 28.305 28.795 28.746 USD -1,351 0.00 Loss of -1,351 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-20	BUY	84	47.930	47.945	47.943	USD 4,027	21.71
2025-10-17	BUY	210	47.900	47.920	47.918	USD 10,063	21.59
2025-10-15	BUY	336	47.890	47.920	47.917	USD 16,100	21.47
2025-10-09	BUY	480	47.850	47.920	47.913	USD 22,998	21.12
2025-10-06	BUY	126	47.870	47.900	47.897	USD 6,035	20.87
2025-10-03	BUY	294	47.900	47.900	47.900	USD 14,083	20.75
2025-10-02	BUY	42	47.870	47.940	47.933	USD 2,013	20.63
2025-09-30	BUY	84	47.830	47.900	47.893	USD 4,023	20.37
2025-09-26	BUY	84	47.740	47.765	47.762	USD 4,012	20.12
2025-09-25	BUY	84	47.720	47.770	47.765	USD 4,012	19.99
2025-09-24	SELL	-708	47.750	47.760	47.759	USD -33,813	19.86 Loss of -19,755 on sale
2025-09-18	BUY	44	47.690	47.770	47.762	USD 2,102	19.72
2025-09-17	BUY	135	47.700	47.750	47.745	USD 6,446	19.59
2025-09-11	SELL	-44	47.600	47.640	47.636	USD -2,096	19.05 Loss of -1,258 on sale
2025-09-10	BUY	88	47.600	47.640	47.636	USD 4,192	18.91
2025-09-05	SELL	-45	26.740	28.455	28.283	USD -1,273	18.67 Loss of -433 on sale
2025-08-29	SELL	-135	23.400	23.420	23.418	USD -3,161	18.57 Loss of -655 on sale
2025-08-27	BUY	90	23.515	24.560	24.455	USD 2,201	18.52
2025-08-26	SELL	-45	23.505	23.580	23.572	USD -1,061	18.49 Loss of -229 on sale
2025-08-25	BUY	45	22.680	23.520	23.436	USD 1,055	18.47
2025-08-20	SELL	-180	22.460	22.750	22.721	USD -4,090	18.43 Loss of -773 on sale
2025-08-18	BUY	90	22.170	22.845	22.777	USD 2,050	18.39
2025-08-08	SELL	-90	20.720	21.670	21.575	USD -1,942	18.30 Loss of -295 on sale
2025-08-05	BUY	44	22.420	22.930	22.879	USD 1,007	18.24
2025-08-01	SELL	-132	21.760	22.340	22.282	USD -2,941	18.20 Loss of -539 on sale
2025-07-30	BUY	176	23.340	23.810	23.763	USD 4,182	18.15
2025-07-17	SELL	-90	18.600	18.930	18.897	USD -1,701	18.07 Loss of -74 on sale
2025-07-11	SELL	-360	17.980	18.080	18.070	USD -6,505	18.06 Loss of -4 on sale
2025-07-07	BUY	135	15.960	16.380	16.338	USD 2,206	18.09
2025-07-02	BUY	2,475	16.190	16.500	16.469	USD 40,761	18.13
2025-06-25	BUY	90	16.990	17.230	17.206	USD 1,549	18.17
2025-06-11	BUY	90	19.095	19.900	19.819	USD 1,784	18.18
2025-06-10	BUY	90	19.000	19.120	19.108	USD 1,720	18.17
2025-06-04	SELL	-46	18.730	19.350	19.288	USD -887	18.15 Loss of -52 on sale
2025-04-23	BUY	45	17.820	18.406	18.348	USD 826	18.69
2025-04-10	SELL	-368	12.100	12.550	12.505	USD -4,602	19.02 Profit of 2,399 on sale
2025-04-08	SELL	-45	12.220	13.400	13.282	USD -598	19.16 Profit of 264 on sale
2025-04-07	SELL	-45	12.620	13.270	13.205	USD -594	19.23 Profit of 271 on sale
2025-04-04	SELL	-230	12.830	13.120	13.091	USD -3,011	19.29 Profit of 1,427 on sale
2025-04-01	BUY	184	14.240	15.180	15.086	USD 2,776	19.41
2025-03-31	SELL	-138	15.210	16.220	16.119	USD -2,224	19.45 Profit of 460 on sale
2025-03-21	BUY	1,284	17.150	17.460	17.429	USD 22,379	19.62
2025-03-14	SELL	-672	18.800	18.820	18.818	USD -12,646	19.75 Profit of 626 on sale
2025-03-07	SELL	-84	14.380	15.660	15.532	USD -1,305	20.01 Profit of 377 on sale
2025-03-04	SELL	-42	12.420	12.760	12.726	USD -534	20.29 Profit of 318 on sale
2025-02-25	BUY	84	12.550	12.720	12.703	USD 1,067	20.84
2025-02-19	SELL	-42	12.600	13.090	13.041	USD -548	21.36 Profit of 349 on sale
2025-02-13	BUY	126	13.090	13.745	13.679	USD 1,724	21.88
2025-02-12	BUY	42	13.230	13.250	13.248	USD 556	22.02
2025-02-11	BUY	168	12.880	13.760	13.672	USD 2,297	22.17
2025-01-17	BUY	164	18.000	18.195	18.175	USD 2,981	24.48
2025-01-16	BUY	164	17.330	18.540	18.419	USD 3,021	24.66
2025-01-10	SELL	-82	19.700	20.210	20.159	USD -1,653	25.27 Profit of 419 on sale
2025-01-08	SELL	-164	20.000	20.350	20.315	USD -3,332	25.57 Profit of 861 on sale
2024-12-30	SELL	-2,182	20.080	20.460	20.422	USD -44,561	25.88 Profit of 11,917 on sale
2024-11-18	SELL	-705	24.520	25.730	25.609	USD -18,054	27.22 Profit of 1,133 on sale
2024-11-08	SELL	-47	28.760	29.545	29.467	USD -1,385	27.18 Loss of -107 on sale
2024-10-21	SELL	-47	28.305	28.795	28.746	USD -1,351	0.00 Loss of -1,351 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TRML

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	43,837	34	100,251	43.7%
2025-09-18	67,782	131	487,086	13.9%
2025-09-17	76,555	11	180,554	42.4%
2025-09-16	29,513	333	98,581	29.9%
2025-09-15	70,034	61	229,955	30.5%
2025-09-12	68,336	128	223,154	30.6%
2025-09-11	108,055	1,447	313,824	34.4%
2025-09-10	107,221	5,190	545,010	19.7%
2025-09-09	2,215,993	7,886	8,384,880	26.4%
2025-09-08	137,882	67	328,349	42.0%
2025-09-05	94,112	0	199,582	47.2%
2025-09-04	89,183	0	120,776	73.8%
2025-09-03	88,575	0	113,165	78.3%
2025-09-02	49,504	0	56,256	88.0%
2025-08-29	42,240	0	49,473	85.4%
2025-08-28	20,280	4	28,865	70.3%
2025-08-27	38,845	0	52,650	73.8%
2025-08-26	31,462	0	42,618	73.8%
2025-08-25	16,134	0	21,952	73.5%
2025-08-22	23,826	0	36,715	64.9%
2025-08-21	24,859	701	39,322	63.2%
2025-08-20	14,552	18	24,244	60.0%
2025-08-19	26,999	0	34,332	78.6%
2025-08-18	86,635	12	124,816	69.4%
2025-08-15	15,384	47	32,478	47.4%
2025-08-14	21,143	150	37,702	56.1%
2025-08-13	25,778	178	38,032	67.8%
2025-08-12	30,079	29	46,958	64.1%
2025-08-11	25,110	12	105,206	23.9%
2025-08-08	32,996	1,085	93,345	35.3%
2025-08-07	42,833	0	54,084	79.2%
2025-08-06	35,063	0	68,011	51.6%
2025-08-05	29,480	16	46,585	63.3%
2025-08-04	19,548	73	71,736	27.2%
2025-08-01	42,562	28	87,355	48.7%
2025-07-31	72,288	56	135,590	53.3%
2025-07-30	60,324	202	95,902	62.9%
2025-07-29	312,855	233	432,374	72.4%
2025-07-28	95,697	51	250,795	38.2%
2025-07-25	49,673	16	115,227	43.1%
2025-07-24	26,079	374	91,334	28.6%
2025-07-23	17,642	0	46,233	38.2%
2025-07-22	14,460	348	27,164	53.2%
2025-07-21	18,966	203	24,327	78.0%
2025-07-18	19,195	0	40,338	47.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE